ISPD 2022 debate 3 ‐ Fetal genome sequencing should be offered to all pregnant patients

Prenatal trio exome sequencing has become integrated into the care of pregnant women when the fetus has structural anomalies. This report is a summary of the debate on this topic at the 26th International Conference on Prenatal Diagnosis and Therapy. Although both debaters weighed the balance of these conflicting arguments differently, they agreed that more research is needed to further explore the clinical utility and ethical aspects of genome sequencing for all pregnant women.